Skip to content

AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.

NO.01Building↑ 32%
Participants counted21
Heat, past 24h
24h agonow
and 21 other sources reporting·21 participants
98
Heat index
NO.02↓ 19%

KRAS

45 sources · 45 participants
68

Page 1 No.04–20

  1. 04

    #PANCREATICCANCERBuilding

    36↑ 40%
  2. 05

    EGFRBuilding

    35↑ 53%
  3. 06

    #BREASTCANCERBuilding

    19↑ 50%
  4. 07

    durvalumabBuilding

    19↑ 408%
  5. 08

    RM-055Building

    16↑ 27%
  6. 09

    HER2

    16↓ 29%
  7. 10

    MR-2088

    15New
  8. 11

    #AVCT

    14↓ 29%
  9. 12

    #LUNGCANCER

    14↓ 29%
  10. 13

    #ANNUALMEETING

    14↓ 29%
  11. 14

    #OVARIANCANCER

    14↓ 29%
  12. 15

    AVA6103Building

    12↑ 81%
  13. 16

    #CANCERDATA

    12↓ 29%
  14. 17

    elisrasib

    12↓ 29%
  15. 18

    MRT-55811Building

    12↑ 129%
  16. 19

    #BIOBANKINGBuilding

    12↑ 266%
  17. 20

    #SITCBuilding

    11↑ 242%
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org